missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Chemicals
  4. Organic compounds
  5. Benzenoids
  6. Benzene and substituted derivatives
  7. Bromobenzenes
  8. CL-387785, MedChemExpress

CL-387785, MedChemExpress

Product Code. 16400086
Encompass_Preferred
Click to view available options
Quantity:
2 mg
5 mg
10 mg
25 mg
50 mg
100 mg
Unit Size:
100mg
10mg
25mg
2mg
50mg
5mg
This item is not returnable. View return policy

Product Code. 16400086

Brand: Medchem Express HY10325

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

MedChemExpress CL-387785(EKI785; WAY-EKI 785) is an irreversible inhibitor of EGFR with IC50 of 370 pM.

CL-387785(EKI785

Specifications

Chemical Name or Material CL-387785
CAS 194423-06-8
Color Light Yellow
Purity Grade Notes Research
Molecular Formula C18H13BrN4O
Quantity 2 mg
Synonym EKI-785 WAY-EKI 785
Solubility Information DMSO : 13.67 mg/mL (35.86 mM; Need ultrasonic and warming)
SMILES O=C(NC1=CC2=C(NC3=CC=CC(Br)=C3)N=CN=C2C=C1)C#CC
Molecular Weight (g/mol) 381.23
Formula Weight 381.23
Percent Purity 98.1%
Grade Research
Physical Form Solid
For Use With (Application) Cancer-Kinase/protease
Show More Show Less

Research purposes only

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.